These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Secondary prevention after myocardial infarction with class III antiarrhythmic drugs. Ceremuzyński L Am J Cardiol; 1993 Nov; 72(16):82F-86F. PubMed ID: 8237835 [TBL] [Abstract][Full Text] [Related]
23. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction. Hockings BE; George T; Mahrous F; Taylor RR; Hajar HA Am J Cardiol; 1987 Nov; 60(13):967-70. PubMed ID: 3673913 [TBL] [Abstract][Full Text] [Related]
25. Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). Schwartz PJ; Camm AJ; Frangin G; Janse MJ; Julian DG; Simon P Eur Heart J; 1994 May; 15(5):620-4. PubMed ID: 8056000 [No Abstract] [Full Text] [Related]
26. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438 [TBL] [Abstract][Full Text] [Related]
27. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877 [TBL] [Abstract][Full Text] [Related]
28. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT): rationale and protocol. CAMIAT Investigators. Cairns JA; Connolly SJ; Roberts R; Gent M Am J Cardiol; 1993 Nov; 72(16):87F-94F. PubMed ID: 8237836 [TBL] [Abstract][Full Text] [Related]
29. Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Pfisterer ME; Kiowski W; Brunner H; Burckhardt D; Burkart F Circulation; 1993 Feb; 87(2):309-11. PubMed ID: 8425280 [TBL] [Abstract][Full Text] [Related]
30. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson WG; Ridker PM JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557 [TBL] [Abstract][Full Text] [Related]
31. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials. Malik M; Camm AJ Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398 [No Abstract] [Full Text] [Related]
32. Lack of effect of amiodarone on survival after extensive infarction. Polish Amiodarone Trial. Budaj A; Kokowicz P; Smielak-Korombel W; Kuch J; Krzemińska-Pakuøa M; Maciejewicz J; Nartowicz E; Zaleska T; Dyduszyński A; Ceremuzyński L Coron Artery Dis; 1996 Apr; 7(4):315-9. PubMed ID: 8853584 [TBL] [Abstract][Full Text] [Related]
33. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators. Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164 [TBL] [Abstract][Full Text] [Related]
34. Amiodarone: a late comer. Futterman LG; Lemberg L Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203 [TBL] [Abstract][Full Text] [Related]
35. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Irvine J; Baker B; Smith J; Jandciu S; Paquette M; Cairns J; Connolly S; Roberts R; Gent M; Dorian P Psychosom Med; 1999; 61(4):566-75. PubMed ID: 10443767 [TBL] [Abstract][Full Text] [Related]
36. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease. Ellison KE; Gandhi G Drugs; 2005; 65(6):787-97. PubMed ID: 15819591 [TBL] [Abstract][Full Text] [Related]
37. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction. Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252 [TBL] [Abstract][Full Text] [Related]
38. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias]. Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360 [TBL] [Abstract][Full Text] [Related]
39. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. Navarro-López F; Cosin J; Marrugat J; Guindo J; Bayes de Luna A Am J Cardiol; 1993 Dec; 72(17):1243-8. PubMed ID: 7504880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]